Prokopeas v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided January 3, 2018·No. 04-1717·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: December 5, 2017

* * * * * * * * * * * * * * * UNPUBLISHED ELLENA PROKOPEAS and * CHRIS PROKOPEAS, parents of * C.A.P., a minor, * * * No. 04-1717V Petitioners, * * v. * Chief Special Master Dorsey * SECRETARY OF HEALTH * Attorneys’ Fees and Costs; Vague AND HUMAN SERVICES, * Entries; Paralegal Tasks; * Administrative Tasks; Autism. Respondent. * * * * * * * * * * * * * * * * Clifford John Shoemaker, Shoemaker, Gentry & Knickelbein, Vienna, VA, for petitioner. Voris Edward Johnson, U.S. Department of Justice, Washington, DC, for respondent.

DECISION AWARDING INTERIM ATTORNEYS’ FEES AND COSTS1 On November 29, 2004, Chris and Ellena Prokopeas (“petitioners”) initially filed a “Short Form Autism” petition for compensation under the National Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-10 et seq. (2012) (“Vaccine Act”), on behalf of their son, C.A.P., a minor. See Short Form Autism Petition For Vaccine Compensation dated Nov. 29, 2004 (ECF No. 1) at 1. By filing that “Short Form Autism” petition, petitioners in effect alleged that C.A.P. suffered from autism, and that his autism was caused by either or both (1) the MMR (measles, mumps, rubella) vaccine, and (2) vaccines containing thimerosal, a mercury-based preservative contained in a number of childhood vaccines until about 1999. See Autism General Order #1, Exhibit A, Master Autism Petition for Vaccine Compensation, 2002 WL 31696785, at *8 (Fed. Cl. Spec. Mstr. July

1 Because this unpublished decision contains a reasoned explanation for the action in this case, the undersigned intends to post this decision on the United States Court of Federal Claims' website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to delete medical or other information, that satisfies the criteria in § 300aa-12(d)(4)(B). Further, consistent with the rule requirement, a motion for redaction must include a proposed redacted decision. If, upon review, the undersigned agrees that the identified material fits within the requirements of that provision, she will delete such material from public access.

1 3, 2002). On August 15, 2011, petitioners filed an amended petition, alleging that C.A.P. “developed encephalopathy from repeated exposures to mercury and other vaccine ingredients” found in certain vaccinations C.A.P. received during his first year of life. See Amended Petition dated Aug. 15, 2011 (ECF No. 51) at 3. Petitioners filed a second amended petition on March 12, 2012, virtually identical to the amended petition filed on August 15, 2011, except that it added certain citations to the petition. See Amended Petition dated Mar. 12, 2012 (ECF No. 57) at 3.

A fact hearing was held in Washington, DC on August 1, 2016. On June 14, 2017, then- Special Master Hastings issued a Ruling on Factual Issues in the case. Prokopeas v. Sec’y of Health & Human Servs., No. 04-1717V, 2017 WL 3033775 (Fed. Cl. June 14, 2017). Petitioners now request an award of interim attorneys’ fees and costs.

I. The Instant Motion

On September 29, 2017, petitioners filed an application for interim attorneys’ fees and costs, requesting $99,037.35 in attorneys’ fees for their counsel, Clifford J. Shoemaker of Shoemaker, Gentry, & Knickelbein (the “Shoemaker Firm”), and $9,795.70 in attorneys’ costs, for a total of $108,833.05. Petitioners (“Pet’rs’”) Application (“App.”) dated September 29, 2017 (ECF No. 147) at 1.2 In accordance with General Order #9, petitioners have filed a signed statement indicating that they incurred out-of-pocket expenses in the amount of $7,723.57. Id. at 1-5. They additionally seek reimbursement of those out-of-pocket expenses. Id. at 1.

Respondent filed a response to petitioners’ interim application on October 6, 2017. Respondent’s Response (“Resp’t’s Resp.”) dated October 6, 2017 (ECF No. 148). Respondent argues that “[n]either the Vaccine Act nor Vaccine Rule 13 contemplates any role for respondent in the resolution of a request by a petitioner for an award of attorneys’ fees and costs.” Id. at 2. Respondent adds, however, that he is “satisfied the statutory requirements for an award of attorneys’ fees and costs are met in this case.” Id. Additionally, he “respectfully recommends that the [undersigned] exercise [her] discretion and determine a reasonable award for [interim] attorneys’ fees and costs.” Id. at 3.

Although respondent does not provide specific objections to the petitioners’ interim fees and costs application, he requests that the undersigned particularly take into account the Ruling on Factual Issues in this case, which, inter alia, provided then-Special Master Hastings’ overall assessment of the petitioners’ experts in the case. Resp’t’s Resp. at 1, n. 1. Citing to the Ruling on Factual Issues, respondent states that the “petitioners’ experts relied on flawed assumptions that were based entirely on parental reports, which are directly contradicted by the medical records,” and requests that the undersigned “should take this factor into consideration” in determining a reasonable award of fees and costs in this instant application. Id. Moreover, respondent states that “at least some of petitioners’ claimed costs appear to relate to evaluations sought in the furtherance

2 Petitioners filed their application for interim attorneys’ fees and costs without proper pagination. See generally Pet’rs’ App. Thus, for ease of reference, the undersigned will use the page numbers generated from the CM/ECF filing reflected at the top of the page. Therefore, the page entitled “Application For Attorneys’ Fees & Costs” will be cited as “Pet’rs’ App. at 1” with subsequent pages numbered accordingly. 2 of C.A.P.’s medical treatment,” and thereby “would not be properly reimbursable as a litigation expense.” Id. Petitioners did not file a reply.

The case was reassigned to the undersigned’s docket on September 12, 2017. See Notice of Reassignment dated Sept. 12, 2017 (ECF No. 144). For the reasons discussed below, the undersigned awards petitioners a total of $80,844.76 in attorneys’ fees and costs to Mr. Clifford J. Shoemaker, and $7,573.57 for petitioners’ out-of-pocket costs.

II. Legal Standard for Interim Attorneys’ Fees and Costs The Federal Circuit has held that an award of interim attorneys’ fees and costs is permissible under the Vaccine Act. Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372 (Fed. Cir. 2010); Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343 (Fed. Cir. 2008). The Circuit has stated, “Congress made clear that denying interim attorneys' fees under the Vaccine Act is contrary to an underlying purpose of the Vaccine Act.” Cloer v. Sec’y of Health & Human Servs., 675 F.3d 1358, 1361-62 (Fed. Cir. 2012).

In Avera, the Federal Circuit stated, “[i]nterim fees are particularly appropriate in cases where proceedings are protracted and costly experts must be retained.” 515 F.3d at 1352. In Shaw, the Federal Circuit held that “where the claimant establishes that the cost of litigation has imposed an undue hardship and there exists a good faith basis for the claim, it is proper for the special master to award interim attorneys' fees.” 609 F.3d at 1375.

Free access — add to your briefcase to read the full text and ask questions with AI

Prokopeas v. Secretary of Health and Human Services, (uscfc 2018).

Prokopeas v. Secretary of Health and Human Services (Prokopeas v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related